ANXA2P2 and cervical cancer: ANXA2P2 knockdown inhibited the growth of DDP-resistant cancer cells and elevated the sensitivity of DDP-resistant cervical cancer cells to DDP, which could be partially restored by miR-361-3p inhibition.